Strides Pharma Science Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 1,301.51 | 1,247.97 | 1,128.32 | 1,202.37 | 1,159.28 |
| Other Income Qtr Cr | 106.86 | 27.14 | 8.58 | 11.98 | 5.62 |
| Operating Revenues Qtr | 1,194.65 | 1,220.83 | 1,119.74 | 1,190.39 | 1,153.67 |
Loading chart... | |||||
Operating Expenses Qtr | 958.70 | 989.26 | 901.66 | 972.52 | 943.36 |
Operating Profit Qtr | 235.94 | 231.57 | 218.07 | 217.87 | 210.31 |
EBITDA Qtr Cr | 339.51 | 249.94 | 218.29 | 202.43 | 213.50 |
Depreciation Qtr | 50.62 | 49.64 | 48.89 | 48.86 | 48.42 |
Net Profit Qtr | 202.11 | 127.53 | 99.61 | 82.19 | 87.95 |
Basic EPS Qtr | 21.93 | 13.84 | 10.81 | 8.92 | 9.56 |
Open Demat Account